Why the study?
Does additional intensive anti-hyperglycemic therapy improve myocardial flow reserve in patients with type 2 diabetes?
Does additional intensive anti-hyperglycemic therapy improve myocardial flow reserve in patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
Intensive anti-hyperglycemic therapy may partially recover myocardial flow reserve in patients with type 2 diabetes, highlighting the importance of glycemic control for coronary microvascular function.
Myocardial Flow Reserve Partially Recovered after Additional Intensive Anti-Hyperglycemic Therapy in Patients with Type 2 Diabetes Impaired myocardial perfusion, such as coronary microangiopathy, is one of the important pathophysiological characteristics of diabetes and a clinically important unresolved clinical question. The importance of glycemic control in the development of atherosclerosis in patients with diabetes has been suggested. We previously reported that myocardial flow reserve (MFR) was related to glycemic control rather than to the mode of therapy in patients with type 2 diabetes (T2DM).
No takes yet. Share an insight, caveat, or question.
Yokoyama et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: